Austin Baraki

Dr. Spencer Nadolsky, an obesity medicine physician and telemedicine innovator, joins Dr. Austin Baraki, a cardiometabolic specialist, to discuss groundbreaking GLP-1 anti-obesity medications. They explore the evolution from short-acting injectables to potent options like Tirzepatide, boasting weight loss similar to bariatric surgery. The duo dives into the benefits of these drugs for cardiovascular and liver health, addresses muscle loss fears, and highlights how resistance training can mitigate risks. They also tackle access issues and the promising future of oral GLP-1 options.